{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:11:26Z","timestamp":1773965486610,"version":"3.50.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023213","name":"European Society for Immunodeficiencies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023213","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Sphingosine phosphate lyase insufficiency syndrome (SPLIS) is associated with biallelic variants in <jats:italic>SGPL1<\/jats:italic>, comprising a multisystemic disease characterized by steroid resistant nephrotic syndrome, primary adrenal insufficiency, neurological problems, skin abnormalities and immunodeficiency in described cases. Signal transducer and activator of transcription 1 (STAT1) plays an important role in orchestrating an appropriate immune response through JAK-STAT pathway. Biallelic <jats:italic>STAT1<\/jats:italic> loss of function (LOF) variants lead to STAT1 deficiency with a severe phenotype of immunodeficiency with increased frequency of infections and poor outcome if untreated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We report novel homozygous SGPL<jats:italic>1<\/jats:italic> and <jats:italic>STAT1<\/jats:italic> variants in a newborn of Gambian ethnicity with clinical features of SPLIS and severe combined immunodeficiency. The patient presented early in life with nephrotic syndrome, severe respiratory infection requiring ventilation, ichthyosis, and hearing loss, with T-cell lymphopenia. The combination of these two conditions led to severe combined immunodeficiency with inability to clear respiratory tract infections of viral, fungal, and bacterial nature, as well as severe nephrotic syndrome. The child sadly died at 6 weeks of age despite targeted treatments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We report the finding of two novel, homozygous variants in <jats:italic>SGPL1<\/jats:italic> and <jats:italic>STAT1<\/jats:italic> in a patient with a severe clinical phenotype and fatal outcome early in life. This case highlights the importance of completing the primary immunodeficiency genetic panel in full to avoid missing a second diagnosis in other patients presenting with similar severe clinical phenotype early in life. For SPLIS no curative treatment is available and more research is needed to investigate different treatment modalities. Hematopoietic stem cell transplantation (HSCT) shows promising results in patients with autosomal recessive STAT1 deficiency. For this patient\u2019s family, identification of the dual diagnosis has important implications for future family planning. In addition, future siblings with the familial <jats:italic>STAT1<\/jats:italic> variant can be offered curative treatment with HSCT.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1186575","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T04:32:46Z","timestamp":1686544366000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Combined novel homozygous variants in both SGPL1 and STAT1 presenting with severe combined immune deficiency: case report and literature review"],"prefix":"10.3389","volume":"14","author":[{"given":"Adriel","family":"Roa-Bautista","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahreen","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Wakeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly C.","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Gait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Lucchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem","family":"Elfeky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaike","family":"Kusters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/S12519-022-00615-4","article-title":"Sphingosine phosphate lyase insufficiency syndrome: a systematic review","volume":"19","author":"Pournasiri","year":"2023","journal-title":"World J Pediatr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI89626","article-title":"Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency","volume":"127","author":"Lovric","year":"2017","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/FPED.2020.00151","article-title":"A sphingosine-1-Phosphate lyase mutation associated with congenital nephrotic syndrome and multiple endocrinopathy","volume":"8","author":"Maharaj","year":"2020","journal-title":"Front Pediatr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3174\/AJNR.A6746","article-title":"MRI Spectrum of brain involvement in sphingosine-1-Phosphate lyase insufficiency syndrome","volume":"41","author":"Martin","year":"2020","journal-title":"AJNR Am J Neuroradiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1194\/JLR.S091181","article-title":"Fifty years of lyase and a moment of truth: sphingosine phosphate lyase from discovery to disease","volume":"60","author":"Saba","year":"2019","journal-title":"J Lipid Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/JIMD.12238","article-title":"Responsiveness of sphingosine phosphate lyase insufficiency syndrome to vitamin B6 cofactor supplementation","volume":"43","author":"Zhao","year":"2020","journal-title":"J Inherit Metab Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/J.JBIOR.2018.09.004","article-title":"Sphingosine phosphate lyase insufficiency syndrome (SPLIS): a novel inborn error of sphingolipid metabolism","volume":"71","author":"Choi","year":"2019","journal-title":"Adv Biol Regul"},{"key":"B8","unstructured":"WeaverKN\n          Sphingosine phosphate lyase insufficiency syndrome\u2019, GeneReviews\u00ae1993"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/J.IMMUNI.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2018.1531704","article-title":"STAT1 and STAT3 mutations: important lessons for clinical immunologists","volume":"14","author":"Olbrich","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/GIM.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B12","first-page":"1","volume-title":"ACGS best practice guidelines for variant classification in rare disease 2020 recommendations ratified by ACGS quality subcommittee on 4 th","author":"Ellard","year":"2020"},{"key":"B13","unstructured":""},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/BRAIN\/AWV182","article-title":"Signal transducer and activator of transcription 2 deficiency is a novel disorder of mitochondrial fission","volume":"138","author":"Shahni","year":"2015","journal-title":"Brain"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/HUMU.23192","article-title":"Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications","volume":"38","author":"Janecke","year":"2017","journal-title":"Hum mutation. Hum Mutat"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90171","article-title":"Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome","volume":"127","author":"Prasad","year":"2017","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0250","article-title":"A retrospective analysis of endocrine disease in sphingosine-1-phosphate lyase insufficiency: case series and literature review","volume":"11","author":"Maharaj","year":"2022","journal-title":"Endocr Connect"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/S10875-022-01348-9","article-title":"SGPL1 deficiency: nephrotic syndrome with lymphopenia","volume":"43","author":"Tran","year":"2023","journal-title":"J Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/CEI\/UXAC106","article-title":"Inborn errors of immunity with loss- and gain-of-function germline mutations in STAT1\u2019","volume":"212","author":"Asano","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.1061154","article-title":"Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation","volume":"293","author":"Dupuis","year":"2001","journal-title":"Sci (New York N.Y.). Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/NG1097","article-title":"Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.176.8.5078","article-title":"Human complete stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo\u2019","volume":"176","author":"Chapgier","year":"2006","journal-title":"J Immunol (Baltimore Md.: 1950)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37083","article-title":"A partial form of recessive STAT1 deficiency in humans","volume":"119","author":"Chapgier","year":"2009","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/S10875-010-9480-8","article-title":"Novel STAT1 alleles in a patient with impaired resistance to mycobacteria","volume":"31","author":"Kristensen","year":"2011","journal-title":". J Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2011-01-330571","article-title":"Severe impairment of IFN-\u03b3 and IFN-\u03b1 responses in cells of a patient with a novel STAT1 splicing mutation","volume":"118","author":"Vairo","year":"2011","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/J.JAIP.2016.02.015","article-title":"A novel presentation of homozygous loss-of-function STAT-1 mutation in an infant with hyperinflammation-a case report and review of the literature\u2019","volume":"4","author":"Burns","year":"2016","journal-title":"J Allergy Clin Immunol In Pract"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1186575\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T04:32:52Z","timestamp":1686544372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1186575\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":26,"alternative-id":["10.3389\/fimmu.2023.1186575"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1186575","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"article-number":"1186575"}}